open federal funding opportunity

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and behavioral symptoms. Par…

Agency

National Institutes of Health

Opportunity number

PAR-25-297